Accendra Health Inc (ACH)
Healthcare
Medical Distribution
—
3.10 $
-7.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Accendra Health Inc (ACH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 73.3% of the shares are freely tradable; institutional investors hold 85.9%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
85.9%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
7.7%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
73.3%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
10.7%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
77Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Coliseum Capital Management LLC | 17.11 | 13,100,807 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 8.25 | 6,318,285 | +6.0 | 12/31/2025 |
| BlackRock Inc | 6.84 | 5,235,300 | -3.3 | 03/31/2026 |
| Charles Schwab Investment Management Inc | 4.75 | 3,635,526 | -10.4 | 03/31/2026 |
| Bank of America Corp | 4.45 | 3,407,075 | +106.9 | 03/31/2026 |
| Invenomic Capital Management, LP | 4.40 | 3,368,975 | -3.8 | 03/31/2026 |
| D. E. Shaw & Co LP | 4.32 | 3,311,601 | -6.9 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.29 | 3,282,174 | +0.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 3.46 | 2,651,152 | +0.0 | 03/31/2026 |
| Dimensional Fund Advisors, Inc. | 3.40 | 2,606,620 | -13.4 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.